Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
215
-
Total 13F shares, excl. options
-
301,421,729
-
Shares change
-
+7,651,038
-
Total reported value, excl. options
-
$3,479,958,222
-
Value change
-
+$96,361,873
-
Put/Call ratio
-
38.92%
-
Number of buys
-
87
-
Number of sells
-
-115
-
Price
-
$11.55
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2021
272 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q4 2021.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 301,421,729 shares
of 308,713,740 outstanding shares and own 97.64% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (26,648,674 shares), PERCEPTIVE ADVISORS LLC (26,559,443 shares), VANGUARD GROUP INC (25,645,184 shares), Redmile Group, LLC (22,716,086 shares), BlackRock Inc. (19,810,348 shares), Avoro Capital Advisors LLC (18,500,000 shares), JPMORGAN CHASE & CO (15,343,828 shares), MORGAN STANLEY (13,640,409 shares), STATE STREET CORP (10,502,065 shares), and Palo Alto Investors LP (10,114,043 shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.